US FDA Plans to Accelerate Approvals for Vapes and Nicotine Pouches
The US Food and Drug Administration plans to introduce measures to accelerate market authorization for electronic cigarettes and nicotine pouches, according to a report from The Wall Street Journal. The policy shift aims to streamline the federal application process for manufacturers seeking marketing clearance.
Under the anticipated plan, the agency will revisit its 2021 rule that outlines requirements for Premarket Tobacco Product Applications (PMTAs). Regulators are expected to simplify the scientific testing criteria and shorten evaluation timelines, granting manufacturers more flexibility to secure product authorizations.
Tobacco and vapor manufacturers have pressed US President Donald Trump and federal health officials to establish a faster, clearer regulatory pathway. The expected changes follow the agency’s recent decision to permit the marketing of three new JUUL2 e-cigarette products, reflecting a stance that authorized electronic alternatives can help adult smokers move away from combustible cigarettes.
An agency spokesperson from the Department of Health and Human Services framed the dual focus of the policy:
“The Trump administration is committed to keeping nicotine out of the hands of kids, getting counterfeit vaping products off the streets and providing safer alternatives for adults who want to quit smoking cigarettes.”
While the administration restricted flavored e-cigarettes during Trump’s first term to curb youth initiation, current efforts center on modernizing application pipelines and clearing out illicit, non-compliant inventory.
- Mexico Passes Stricter Tobacco Law as Experts Warn of Cartel Trade - October 9, 2026
- FDA Tobacco Review Delays Threaten Public Health, GAO Report Reveals - October 9, 2026
- USA Northeast Vape Laws in 2026: State Taxes & Flavor Bans - October 9, 2026









